semaglutide essence trial for MASH in #ESSENCE #Semaglutide hits both primary endpoints in NASH trial π62.9% resolved steatohepatitis (vs 34.3% placebo) π36.8% showed fibrosis improvement (vs 22.4% placebo) πCombined response: 32.7% vs 16.1% Diabetes Dialogue: Semaglutide for MASH
Pay in 4 interest-free payments of $6.28 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 16 - Aug 21





















